Active Filters

Results of S1417CD
Jan 4, 2022
Major financial hardship common after cancer diagnosis, despite insurance
Anjali Advani, MD
Dec 13, 2021
Combo with immunotherapy drug can be effective in patients who are not good candidates for chemo
Megan Othus, PhD
Dec 11, 2021
Analyses presented at ASH 2021 find statistical models can predict risk of early death with non-intensive AML therapy
Corey W. Speers, MD, PhD
Dec 9, 2021
Results at SABCS show assay has prognostic value that complements value of recurrence score in postmenopausal patients
RxPONDER Trial Results: Kevin Kalinsky, MD
Dec 1, 2021
RxPONDER finds postmenopausal women with HR+, HER2- breast cancer with 1-3 involved nodes and an RS of 25 or less can safely skip chemo
ESMO Congress 2021
Sep 20, 2021
Forty years of publicly funded trials added 14 million years of life for cancer patients and profoundly affected cancer care guidelines
Clinical Cancer Research article
Sep 14, 2021
A blood serum test can identify which patients have slow-growing disease that might be controlled with an aromatase inhibitor alone.